Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Total Debt / Equity

Albireo Pharma Inc Total Debt / Equity Chart (ALBO)

Albireo Pharma Inc annual/quarterly Total Debt / Equity from 2015 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Albireo Pharma Inc Total Debt / Equity for the quarter ending June 06, 2020 was $16m a 69.79% increase of 11m year over year
  • Albireo Pharma Inc Total Debt / Equity for the last 12 months ending June 06, 2020 was $16m a 69.79% increase of 11m year over year
  • Albireo Pharma Inc Annual Total Debt / Equity for 2019 was $5m a -63.32% decrease of -3m from 2018
  • Albireo Pharma Inc Annual Total Debt / Equity for 2016 was $8m a 1,178.76% increase of 98m from 2015
  • Albireo Pharma Inc Annual Total Debt / Equity for 2015 was $-90m a -302.71% increase of 272m from 2014
Other Ratios Metrics:
  • Albireo Pharma Inc Total Debt / Capital for the quarter ending September 09, 2017 was $2m a -268.92% decrease of -6m year over year
  • Albireo Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $50m a 8.86% increase of 4m year over year
View Chart On Koyfin

Quarterly ALBO Total Debt / Equity Data

06/2020$16m
03/2020$4m
12/2019$5m
09/2019$5m
06/2019$0m
03/2019$0m
09/2017$2m
06/2017$3m
03/2017$8m
12/2016$8m

Annual ALBO Total Debt / Equity Data

2019$5m
2016$8m
2015$-90m
2014$-362m